In MS early inflammatory stages, activated immune cells highly produce pro-inflammatory factors including interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α), which not only are cytotoxic but also induce glial reactivity leading to an exacerbated local inflammation, including the expression of astroglial S100B protein. Here, S100B is linked to myeloid sarcoma.